Results 61 to 70 of about 5,151 (175)

Biopsy-proven progressive multifocal leukoencephalopathy in a renal transplant patient

Saudi Journal of Kidney Diseases and Transplantation, 2019
Progressive multifocal leukoencephalopathy (PML) is a rare demyelinating disease that affects immunocompromised hosts. Most often the disease is reported in association with leukemia, lymphoma, and AIDS.
Pramod Kumar Guru, Megan B Vissing, Anjali Agarwal, Murli Krishna   +3 more
doaj   +1 more source

Hemianopia and visual loss due to progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis

Clinical Ophthalmology, 2012
Tina Rike Herold,1 Veronika Jakl,3 Anno Graser,4 Kirsten Eibl-Lindner1,21Department of Ophthalmology, 2Department of Ophthalmology, Campus Innenstadt, 3Department of Neurology, 4Department of Clinical Radiology, Campus Grosshadern, University of Munich ...
Herold TR, Jakl V, Graser A, Eibl-Lindner K   +3 more
doaj  

Case report: Progressive multifocal leukoencephalopathy co-occurring with neurosarcoidosis: early brain biopsy and appropriate therapy for PML resulted in a favorable prognosis

Frontiers in Immunology
Progressive multifocal leukoencephalopathy (PML) is a rare central nervous system disease caused by JC virus (JCV) infection. Human immunodeficiency virus (HIV) infection is the greatest risk factor for PML.
Qiannan Wang, Shintaro Tsuboguchi, Kouichirou Okamoto, Mari Tada, Akiyoshi Kakita, Kazuo Nakamichi, Makoto Oishi, Masato Kanazawa, Osamu Onodera   +8 more
doaj   +1 more source

Progressive multifocal leukoencephalopathy: new concepts

Arquivos de Neuro-Psiquiatria, 2013
Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the CNS caused by reactivation of JC virus (JCV) in a setting of cellular immunosuppression.
Marco A. Lima
doaj   +1 more source

Long-term safety and efficacy of natalizumab in relapsing-remitting multiple sclerosis: impact on quality of life

Patient Related Outcome Measures, 2014
Raquel Planas, Roland Martin, Mireia Sospedra Neuroimmunology and MS Research, Department of Neurology, University of Zurich, Zurich, Switzerland Abstract: Natalizumab was the first monoclonal antibody to be approved for the treatment of relapsing ...
Planas R, Martin R, Sospedra M
doaj  

Progressive Multifocal Leukoencephalopathy in an Immunocompetent Taiwanese Patient

Journal of the Formosan Medical Association, 2007
Progressive multifocal leukoencephalopathy (PML) is a deadly demyelinating brain disease caused by JC virus (JCV). Genomic analysis of viral isolates in these cases often shows prototype-like JCV and its variants, which is a virulent strain compared to ...
Yung-Yee Chang, Min-Yu Lan, Cheng-Huei Peng, Hsiu-Shan Wu, DeChing Chang, Jia-Shou Liu   +5 more
doaj   +1 more source

Misdiagnosed Progressive Multifocal Leukoencephalopathy (PML) in an HIV-Negative Patient With Discoid Lupus: A Case Report. [PDF]

Cureus, 2023
Mousa A, Rashid MH, Arslan K, Lofrese CN, Najeeb N.   +4 more
europepmc   +1 more source

Progressive multifocal leukoencephalopathy as a complication of disease-modifying treatment of multiple sclerosis

Анналы клинической и экспериментальной неврологии, 2018
The review provides modern understanding of the pathogenesis of progressive multifocal leukoencephalopathy (PML), a severe and potentially fatal form of multiple-lesion disorder of the brain white matter.
Maria N. Zakharova, Elena V. Lysogorskaia, Maria V. Ivanova, Ivan А. Kochergin, Yulia E. Korzhova   +4 more
doaj   +1 more source

Diagnostic difficulties in progressive multifocal leukoencephalopathy: a case report

Folia Neuropathologica
Progressive multifocal leukoencephalopathy (PML) is a demyelination disease of the central nervous system (CNS) caused by viral infection with John Cunningham polyomavirus (JC virus, JCV). PML affects mainly patients with immunodeficiency.
Angelika Stapińska-Syniec, Michał Sobstyl, Katarzyna Kurowska, Albert Acewicz, Teresa Wierzba-Bobrowicz   +4 more
doaj   +1 more source

A case report of simultaneous PML-IRIS during corticosteroids tapering in a patient with an anti-synthetase syndrome [v1; ref status: indexed, http://f1000r.es/2l6]

F1000Research, 2013
We report a case of simultaneous progressive multifocal leukoencephalopathy-associated immune reconstitution inflammatory syndrome (PML-IRIS) during corticosteroid tapering in a patient with an anti-synthetase syndrome.
Guillaume Martin-Blondel, David Brassat, Hervé Dumas, Emmanuelle Uro-Coste, Daniel Adoue, Hans Lassmann, Michel Clanet   +6 more
doaj   +1 more source